Annual Net Income
-$75.34 M
+$29.27 M+27.98%
31 March 2024
Summary:
Portage Biotech annual net profit is currently -$75.34 million, with the most recent change of +$29.27 million (+27.98%) on 31 March 2024. During the last 3 years, it has fallen by -$59.51 million (-375.84%). PRTG annual net income is now -160.88% below its all-time high of $123.74 million, reached on 31 March 2018.PRTG Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$1.36 M
+$296.00 K+17.87%
30 September 2024
Summary:
Portage Biotech quarterly net profit is currently -$1.36 million, with the most recent change of +$296.00 thousand (+17.87%) on 30 September 2024. Over the past year, it has increased by +$38.01 million (+96.55%). PRTG quarterly net income is now -101.09% below its all-time high of $124.77 million, reached on 31 March 2018.PRTG Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$67.28 M
+$3.80 M+5.34%
30 September 2024
Summary:
Portage Biotech TTM net profit is currently -$67.28 million, with the most recent change of +$3.80 million (+5.34%) on 30 September 2024. Over the past year, it has increased by +$77.62 million (+53.57%). PRTG TTM net income is now -154.24% below its all-time high of $124.03 million, reached on 31 December 2018.PRTG TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTG Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +28.0% | +96.5% | +53.6% |
| 3 y3 years | -375.8% | +61.3% | -219.6% |
| 5 y5 years | -2759.2% | -3.3% | -1029.8% |
PRTG Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -375.8% | +28.0% | -43.3% | +98.6% | -398.1% | +53.6% |
| 5 y | 5 years | -2759.2% | +28.0% | -95.4% | +98.6% | -1366.7% | +53.6% |
| alltime | all time | -160.9% | +28.0% | -101.1% | +98.6% | -154.2% | +53.6% |
Portage Biotech Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.36 M(-17.9%) | -$67.28 M(-5.3%) |
| June 2024 | - | -$1.66 M(-93.3%) | -$71.08 M(-5.7%) |
| Mar 2024 | -$75.34 M(-28.0%) | -$24.89 M(-36.8%) | -$75.34 M(-48.0%) |
| Dec 2023 | - | -$39.37 M(+663.3%) | -$144.90 M(+28.2%) |
| Sept 2023 | - | -$5.16 M(-12.9%) | -$113.01 M(+3.9%) |
| June 2023 | - | -$5.92 M(-93.7%) | -$108.80 M(+4.0%) |
| Mar 2023 | -$104.61 M(+520.1%) | -$94.45 M(+1161.8%) | -$104.61 M(+498.5%) |
| Dec 2022 | - | -$7.49 M(+688.7%) | -$17.48 M(+29.4%) |
| Sept 2022 | - | -$949.00 K(-45.1%) | -$13.51 M(-13.0%) |
| June 2022 | - | -$1.73 M(-76.4%) | -$15.53 M(-7.9%) |
| Mar 2022 | -$16.87 M(+6.5%) | -$7.32 M(+108.3%) | -$16.87 M(-19.9%) |
| Dec 2021 | - | -$3.51 M(+18.1%) | -$21.05 M(+12.4%) |
| Sept 2021 | - | -$2.98 M(-3.0%) | -$18.72 M(+2.9%) |
| June 2021 | - | -$3.07 M(-73.3%) | -$18.20 M(+15.0%) |
| Mar 2021 | -$15.83 M(+196.9%) | -$11.50 M(+871.1%) | -$15.83 M(+180.9%) |
| Dec 2020 | - | -$1.18 M(-51.8%) | -$5.64 M(-2.3%) |
| Sept 2020 | - | -$2.46 M(+252.7%) | -$5.77 M(+25.8%) |
| June 2020 | - | -$696.00 K(-46.5%) | -$4.59 M(-14.0%) |
| Mar 2020 | -$5.33 M(+102.4%) | -$1.30 M(-1.1%) | -$5.33 M(-10.4%) |
| Dec 2019 | - | -$1.32 M(+3.4%) | -$5.96 M(+20.4%) |
| Sept 2019 | - | -$1.27 M(-11.7%) | -$4.95 M(+27.4%) |
| June 2019 | - | -$1.44 M(-25.1%) | -$3.88 M(+46.0%) |
| Mar 2019 | -$2.63 M(-102.1%) | -$1.92 M(+526.7%) | -$2.66 M(-102.1%) |
| Dec 2018 | - | -$307.00 K(+47.6%) | $124.03 M(+0.0%) |
| Sept 2018 | - | -$208.00 K(-5.0%) | $123.99 M(+0.1%) |
| June 2018 | - | -$219.00 K(-100.2%) | $123.86 M(+0.1%) |
| Mar 2018 | $123.74 M(+659.2%) | $124.77 M(<-9900.0%) | $123.74 M(-1362.0%) |
| Dec 2017 | - | -$351.00 K(+2.9%) | -$9.80 M(-36.9%) |
| Sept 2017 | - | -$341.00 K(+2.4%) | -$15.53 M(-183.1%) |
| June 2017 | - | -$333.00 K(-96.2%) | $18.68 M(+14.6%) |
| Mar 2017 | $16.30 M(-385.6%) | -$8.78 M(+44.6%) | $16.30 M(-31.9%) |
| Dec 2016 | - | -$6.07 M(-117.9%) | $23.93 M(-12.2%) |
| Sept 2016 | - | $33.86 M(-1349.7%) | $27.25 M(-457.4%) |
| June 2016 | - | -$2.71 M(+136.7%) | -$7.62 M(+33.6%) |
| Mar 2016 | -$5.71 M(+83.0%) | -$1.14 M(-58.4%) | -$5.71 M(+3.2%) |
| Dec 2015 | - | -$2.75 M(+171.3%) | -$5.53 M(+62.1%) |
| Sept 2015 | - | -$1.02 M(+28.4%) | -$3.41 M(+9.2%) |
| June 2015 | - | -$790.90 K(-18.2%) | -$3.12 M(+0.2%) |
| Mar 2015 | -$3.12 M(-50.5%) | -$966.90 K(+51.7%) | -$3.12 M(-18.3%) |
| Dec 2014 | - | -$637.20 K(-12.6%) | -$3.82 M(+9.9%) |
| Sept 2014 | - | -$728.70 K(-7.2%) | -$3.47 M(+12.3%) |
| June 2014 | - | -$785.60 K(-52.8%) | -$3.09 M(-51.0%) |
| Mar 2014 | -$6.30 M(+335.8%) | -$1.67 M(+470.2%) | -$6.30 M(+23.2%) |
| Dec 2013 | - | -$292.20 K(-16.1%) | -$5.12 M(+13.5%) |
| Sept 2013 | - | -$348.30 K(-91.3%) | -$4.51 M(-29.2%) |
| June 2013 | - | -$4.00 M(+732.3%) | -$6.37 M(+327.6%) |
| Mar 2013 | -$1.45 M | -$480.40 K(-252.3%) | -$1.49 M(-4.6%) |
| Dec 2012 | - | $315.50 K(-114.3%) | -$1.56 M(-31.7%) |
| Sept 2012 | - | -$2.21 M(-350.3%) | -$2.29 M(+213.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $881.50 K(-259.6%) | -$728.30 K(-71.0%) |
| Mar 2012 | -$2.48 M(-35.5%) | -$552.40 K(+35.2%) | -$2.51 M(-13.9%) |
| Dec 2011 | - | -$408.60 K(-37.0%) | -$2.92 M(-18.4%) |
| Sept 2011 | - | -$648.80 K(-28.1%) | -$3.57 M(-15.2%) |
| June 2011 | - | -$901.90 K(-5.7%) | -$4.21 M(+11.7%) |
| Mar 2011 | -$3.84 M(-0.4%) | -$956.70 K(-10.1%) | -$3.77 M(-26.6%) |
| Dec 2010 | - | -$1.06 M(-17.4%) | -$5.14 M(+9.9%) |
| Sept 2010 | - | -$1.29 M(+179.6%) | -$4.68 M(+14.0%) |
| June 2010 | - | -$460.70 K(-80.2%) | -$4.10 M(+7.4%) |
| Mar 2010 | -$3.85 M(+605.6%) | -$2.32 M(+285.9%) | -$3.82 M(+125.7%) |
| Dec 2009 | - | -$602.50 K(-15.6%) | -$1.69 M(+28.6%) |
| Sept 2009 | - | -$713.90 K(+303.1%) | -$1.32 M(+82.3%) |
| June 2009 | - | -$177.10 K(-10.8%) | -$722.00 K(+27.8%) |
| Mar 2009 | -$546.00 K(-1.7%) | -$198.60 K(-12.4%) | -$564.80 K(+76.4%) |
| Dec 2008 | - | -$226.60 K(+89.3%) | -$320.20 K(+20.6%) |
| Sept 2008 | - | -$119.70 K(+501.5%) | -$265.50 K(-29.4%) |
| June 2008 | - | -$19.90 K(-143.3%) | -$375.80 K(-24.4%) |
| Mar 2008 | -$555.50 K(-210.5%) | $46.00 K(-126.8%) | -$497.20 K(-236.3%) |
| Dec 2007 | - | -$171.90 K(-25.3%) | $364.80 K(-31.7%) |
| Sept 2007 | - | -$230.00 K(+62.8%) | $534.50 K(-21.7%) |
| June 2007 | - | -$141.30 K(-115.6%) | $682.60 K(+41.0%) |
| Mar 2007 | $502.60 K(-120.0%) | $908.00 K(<-9900.0%) | $484.10 K(-56.3%) |
| Dec 2006 | - | -$2200.00(-97.3%) | $1.11 M(+13.5%) |
| Sept 2006 | - | -$81.90 K(-75.9%) | $975.30 K(-159.1%) |
| June 2006 | - | -$339.80 K(-122.2%) | -$1.65 M(-32.5%) |
| Mar 2006 | -$2.51 M(-39.9%) | $1.53 M(-1246.4%) | -$2.45 M(-67.1%) |
| Dec 2005 | - | -$133.50 K(-95.1%) | -$7.44 M(+0.5%) |
| Sept 2005 | - | -$2.71 M(+138.4%) | -$7.41 M(+50.1%) |
| June 2005 | - | -$1.14 M(-67.2%) | -$4.93 M(+21.3%) |
| Mar 2005 | -$4.18 M(+302.7%) | -$3.47 M(+3450.6%) | -$4.07 M(+178.2%) |
| Dec 2004 | - | -$97.60 K(-58.5%) | -$1.46 M(+3.4%) |
| Sept 2004 | - | -$234.90 K(-13.1%) | -$1.41 M(+10.8%) |
| June 2004 | - | -$270.20 K(-68.6%) | -$1.28 M(+23.5%) |
| Mar 2004 | -$1.04 M(+377.0%) | -$859.40 K(+1646.7%) | -$1.03 M(+396.1%) |
| Dec 2003 | - | -$49.20 K(-49.2%) | -$208.20 K(-14.6%) |
| Sept 2003 | - | -$96.90 K(+254.9%) | -$243.90 K(+21.8%) |
| June 2003 | - | -$27.30 K(-21.6%) | -$200.20 K(-8.5%) |
| Mar 2003 | -$217.60 K(-74.0%) | -$34.80 K(-59.0%) | -$218.90 K(-48.7%) |
| Dec 2002 | - | -$84.90 K(+59.6%) | -$426.30 K(-49.0%) |
| Sept 2002 | - | -$53.20 K(+15.7%) | -$835.50 K(-0.0%) |
| June 2002 | - | -$46.00 K(-81.0%) | -$835.90 K(-0.3%) |
| Mar 2002 | -$835.70 K(-23.3%) | -$242.20 K(-51.0%) | -$838.60 K(-14.5%) |
| Dec 2001 | - | -$494.10 K(+821.8%) | -$981.10 K(+17.5%) |
| Sept 2001 | - | -$53.60 K(+10.1%) | -$834.80 K(+6.9%) |
| June 2001 | - | -$48.70 K(-87.3%) | -$781.20 K(+6.6%) |
| Mar 2001 | -$1.09 M(+13.8%) | -$384.70 K(+10.6%) | -$732.50 K(+110.6%) |
| Dec 2000 | - | -$347.80 K | -$347.80 K |
| Mar 2000 | -$957.30 K(+202.5%) | - | - |
| Mar 1999 | -$316.50 K(-20.2%) | - | - |
| Mar 1998 | -$396.60 K | - | - |
FAQ
- What is Portage Biotech annual net profit?
- What is the all time high annual net income for Portage Biotech?
- What is Portage Biotech annual net income year-on-year change?
- What is Portage Biotech quarterly net profit?
- What is the all time high quarterly net income for Portage Biotech?
- What is Portage Biotech quarterly net income year-on-year change?
- What is Portage Biotech TTM net profit?
- What is the all time high TTM net income for Portage Biotech?
- What is Portage Biotech TTM net income year-on-year change?
What is Portage Biotech annual net profit?
The current annual net income of PRTG is -$75.34 M
What is the all time high annual net income for Portage Biotech?
Portage Biotech all-time high annual net profit is $123.74 M
What is Portage Biotech annual net income year-on-year change?
Over the past year, PRTG annual net profit has changed by +$29.27 M (+27.98%)
What is Portage Biotech quarterly net profit?
The current quarterly net income of PRTG is -$1.36 M
What is the all time high quarterly net income for Portage Biotech?
Portage Biotech all-time high quarterly net profit is $124.77 M
What is Portage Biotech quarterly net income year-on-year change?
Over the past year, PRTG quarterly net profit has changed by +$38.01 M (+96.55%)
What is Portage Biotech TTM net profit?
The current TTM net income of PRTG is -$67.28 M
What is the all time high TTM net income for Portage Biotech?
Portage Biotech all-time high TTM net profit is $124.03 M
What is Portage Biotech TTM net income year-on-year change?
Over the past year, PRTG TTM net profit has changed by +$77.62 M (+53.57%)